Printer Friendly
The Free Library
14,505,210 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Takara Bio Sets up New Research Division at Institute for Protein Research, Osaka University.


Tokyo, Japan, Sept 30, 2005 - (JCNN JCNN Japan Corporate News Network ) - Takara Bio announced on September 27 that it will donate 100 million yen to the Institute for Protein Research, Osaka University Home to many elite and renowned alumni of CEOs, lawyers, doctors, scientists, bureaucrats, and a Nobel laureate, as well as to many advanced research centers, Osaka University is considered one of the most prestigious universities in Japan and Asia.  in order to set up a new research division.

The new division named Biomolecular Recognition (Takara Bio) <?> will proceed with research on the action mechanism of Takara Bio's proprietary function food compounds.

Under the supervision of Director Morikawa of the Biomolecular Engineering Research Institute (BERI), the division will strive to elucidate e·lu·ci·date  
v. e·lu·ci·dat·ed, e·lu·ci·dat·ing, e·lu·ci·dates

v.tr.
To make clear or plain, especially by explanation; clarify.

v.intr.
To give an explanation that serves to clarify.
 the interactions of the compounds and target proteins.

With this move, the company aims to deepen its expertise in the development of functional food compounds as well as apply findings in the field of medicine.

Source: JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
 http://www.japancorp.net

Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Oct 4, 2005
Words:129
Previous Article:Dainippon Sumitomo Pharma Kicks off Operations.
Next Article:Info Plant Announces Results of Survey of Youth in East Asia on MP3 Players.



Related Articles
NANOSPHERE/TAKARO BIO FORM DEVELOP/DISTRIBUTE ALLIANCE.
Takara Bio Releases High-fidelity PCR Enzyme PrimeSTAR HS DNA Polymerase.
Takara Bio Discovers Seven New RNA Interference Enzymes.
Takara Bio Sheds Light on Anti-inflammatory Mechanism of Agaro-oligosaccharide.
Takara Bio Introduces New Protein Expression System.
Takara Bio, MolMed Announce That Phase I/II Clinical Trial of HSV-TK Gene Therapy Delivers Positive Results.
Takara Bio Chinese Subsidiary to Expand Lines of Business, Files Chinese Clinical Trial Application.
Takara Bio Licenses FLT3 Gene Mutation Detection Method to InVivoScribe Technologies.
Rapid genome sequencing of RNA viruses.(DISPATCHES)
Takara Bio Grants Transgenomic License for LA-PCR Technology.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles